Inventia Healthcare Limited Gliclazide Export Data — India (DGFT 2022–2026)

Name: Inventia Healthcare Limited Gliclazide Export Records India — #13 Exporter, 134 Shipments, $2.0M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-04-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Gliclazide

India Pharmaceutical Trade Intelligence

$300.8M238 Suppliers109 CountriesHS 30049099

ExportsIndia → HUNGARY29.3%India → NETHERLANDS29.2%

ImportsUNITED KINGDOM → India$1.0M BULGARIA → India$261.6K

#1 Supplier: MYLAN LABORATORIES #1 Buyer: MYLAN HUNGARY

Inventia Healthcare Limited — Gliclazide Exporter #13 | $2.0M Trade Value | TransData Nexus | TransData Nexus

Inventia Healthcare Limited — Gliclazide Exporter Profile

Indian Pharmaceutical Exporter · #13 for Gliclazide · $2.0M export value · DGFT Verified

Inventia Healthcare Limited is the #13 Indian exporter of Gliclazide with $2.0M in export value and 134 verified shipments. Inventia Healthcare Limited holds a 0.7% market share in Gliclazide exports across 6 countries. The company exports 11 pharmaceutical products worth $36.5M across 6 therapeutic categories.

Inventia Healthcare Limited — Gliclazide Export Profile: Buyers & Destinations

Inventia Healthcare Limited Gliclazide export treemap — buyers and destination countries | TransData Nexus

Where Does Inventia Healthcare Limited Export Gliclazide?

Country	Value	Shipments	Share
SRI LANKA	$815.3K	75	45.1%
VIETNAM, DEMOCRATIC REP. OF	$477.1K	21	26.4%
VIETNAM	$260.4K	7	14.4%
VIETNAM DEMOCRATIC REP. OF	$161.2K	9	8.9%

Who Are the Top Buyers of Gliclazide from Inventia Healthcare Limited?

Buyer	Country	Value	Orders
MAXXCARE COMPANY LIMITED	VIETNAM, DEMOCRATIC REP. OF	$458.9K	18
MAXXCARE COMPANY LIMITED,	VIETNAM, DEMOCRATIC REP. OF	$286.1K	12
TO THE HSBC BANK	SRI LANKA	$271.7K	21
MAXXCARE COMPANY LIMITED.	VIETNAM, DEMOCRATIC REP. OF	$153.6K	7
TO THE ORDER	SRI LANKA	$131.4K	11
TO DFCC BANK PLC	SRI LANKA	$71.9K	6
TO SAMPATH BANK PLC	SRI LANKA	$47.8K	7
CHEM-I-PLAST PTY LIMITED	SRI LANKA	$44.9K	4
TO SAMPATH BANK PLC.	SRI LANKA	$43.7K	2
MEGA LIFESCIENCES PTY LIMITED	CAMBODIA	$32.3K	8

Inventia Healthcare Limited supplies Gliclazide to 15 buyers globally. The largest buyer is MAXXCARE COMPANY LIMITED (VIETNAM, DEMOCRATIC REP. OF), followed by MAXXCARE COMPANY LIMITED, (VIETNAM, DEMOCRATIC REP. OF) and TO THE HSBC BANK (SRI LANKA). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.

What Gliclazide Formulations Does Inventia Healthcare Limited Export?

Product Description / Formulation	Value	Shipments
Glitrol CR 60 Gliclazide Controlled Release Capsules 60 mg FINISHED PHARMACEUTICALS PRODUCTS 10 X 10 AS PER THE PI	$158.8K	4
Glitrol CR 60 (Gliclazide Controlled Rel	$147.1K	15
GLY 4 PAR 30 -(GLICLAZIDE EXTENDEDRELEASE TABLETS 30 MG)	$103.6K	6
GLY 4 PAR 60 -(GLICLAZIDE EXTENDED RELEA	$98.1K	3
GLY 4 PAR 30 -GLICLAZIDE EXTENDED RELEASE TABLETS 30 MG	$92.5K	2
GLY 4 PAR 30 -(GLICLAZIDE EXTENDED RELEA	$92.1K	4
GLY 4 PAR 30 (GLICLAZIDE EXTENDED RELEASE TABLETS 30 MG)NOS	$91.7K	3
GLY 4 PAR 60 -GLICLAZIDE EXTENDED RELEASE TABLETS 60 MG	$79.2K	2
GLY 4 PAR 60(Gliclazide Extended Release	$67.2K	4
GLY 4 PAR 60 -Gliclazide Extended Relea	$59.4K	2

Inventia Healthcare Limited exports 61 distinct Gliclazide formulations including tablets, capsules, syrups, and combination drugs. The top formulation is Glitrol CR 60 Gliclazide Controlled Release Capsules 60 mg F with 4 shipments worth $158.8K.

How Does Inventia Healthcare Limited Compare to Nearest Gliclazide Exporters?

Exporters ranked immediately above and below #13 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
11	TORRENT PHARMACEUTICALS LIMITED	$2.5M	83	2	$30.7K
2	PANACEA BIOTEC PHARMA LIMITED	$2.5M	50	5	$50.0K
13	INVENTIA HEALTHCARE LIMITED ★	$2.0M	134	6	$14.8K
14	ALKEM LABORATORIES LIMITED	$2.0M	68	2	$29.2K
12	CENTAUR PHARMACEUTICALS PRIVATE LIMITED	$1.8M	36	9	$50.0K

Inventia Healthcare Limited ranks #13 among 238 Indian Gliclazide exporters. Average shipment value of $14.8K compared to the market average of $287.6K. The closest competitors by value are TORRENT PHARMACEUTICALS LIMITED and PANACEA BIOTEC PHARMA LIMITED.

Which Indian Ports Ship Gliclazide Exports?

Port	Shipments	% Share
NHAVA SHEVA SEA (INNSA1)	439	11.5%
SAHAR AIR	375	9.8%
JNPT/ NHAVA SHEVA SEA	323	8.4%
SAHAR AIR CARGO ACC (INBOM4)	247	6.4%
DELHI AIR	229	6.0%
JNPT	203	5.3%
DELHI AIR CARGO ACC (INDEL4)	165	4.3%
CMA CGM LOGISTICS PARK ICD	103	2.7%

Geopolitical & Trade Policy Impact on Inventia Healthcare Limited's Gliclazide Exports

Inventia Healthcare's extensive export operations are currently navigating a complex geopolitical landscape that presents both challenges and opportunities. The ongoing Israel-Iran tensions have led to disruptions in Red Sea shipping routes, resulting in increased freight costs and extended transit times. These logistical challenges are particularly impactful for time-sensitive pharmaceutical shipments, necessitating strategic adjustments in supply chain management to mitigate potential delays and cost escalations. (pharmaceuticalcommerce.com)

In the United States, recent tariff implementations have introduced additional complexities for Indian pharmaceutical exporters. The imposition of tariffs on a broad range of imports, including pharmaceuticals, has raised concerns about cost competitiveness and market access. Companies like Inventia must navigate these policy shifts by exploring alternative markets and enhancing operational efficiencies to maintain their competitive edge. (apnews.com)

Conversely, the European Union's stringent regulatory frameworks, such as the Falsified Medicines Directive, necessitate rigorous compliance measures. While these regulations impose additional operational requirements, they also present an opportunity for companies with robust quality systems to differentiate themselves. Inventia's adherence to international quality standards positions it favorably to meet these regulatory demands and strengthen its presence in the European market.

Inventia Healthcare Limited — Regulatory Compliance & Quality Standards

The global pharmaceutical industry is witnessing heightened regulatory scrutiny, with agencies like the U.S. FDA and the European Medicines Agency intensifying their focus on manufacturing practices and product quality. For Indian exporters, this translates into the necessity for stringent compliance with Good Manufacturing Practices (GMP) and other regulatory standards.

Inventia Healthcare's manufacturing facility in Ambernath and its research and development center in Thane are accredited by the U.S. FDA, U.K. MHRA, and other stringent regulatory authorities. This compliance underscores the company's commitment to maintaining high-quality standards, facilitating access to both emerging and regulated markets. (platinumequity.com)

However, the broader Indian pharmaceutical sector faces challenges related to quality assurance, with instances of regulatory non-compliance affecting the industry's reputation. To mitigate these risks, companies like Inventia must continually invest in quality control systems, employee training, and process improvements to ensure sustained compliance and market trust.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Gliclazide shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: Inventia Healthcare Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
4.Verified Records: This page is backed by 134 individual customs records matching Inventia Healthcare Limited exporting Gliclazide, covering 61 formulations to 8 countries via 15 buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 109+ countries, 643+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Gliclazide

Gliclazide

Inventia Healthcare Limited — Gliclazide Exporter Profile

Inventia Healthcare Limited — Gliclazide Export Profile: Buyers & Destinations

Where Does Inventia Healthcare Limited Export Gliclazide?

Who Are the Top Buyers of Gliclazide from Inventia Healthcare Limited?

What Is India's Total Gliclazide Export Value and How Much Does Inventia Healthcare Limited Contribute?

What Is the Average Shipment Value for Inventia Healthcare Limited's Gliclazide Exports?

How Does Inventia Healthcare Limited Compare to Other Indian Gliclazide Exporters?

What Gliclazide Formulations Does Inventia Healthcare Limited Export?

How Does Inventia Healthcare Limited Compare to Nearest Gliclazide Exporters?

Which Indian Ports Ship Gliclazide Exports?

What Other Advanced Diabetes Medications Products Does Inventia Healthcare Limited Export?

Geopolitical & Trade Policy Impact on Inventia Healthcare Limited's Gliclazide Exports

Inventia Healthcare Limited — Regulatory Compliance & Quality Standards

About Inventia Healthcare Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Gliclazide Export Data from Inventia Healthcare Limited

Gliclazide Stats

Company Overview

Top Products by Inventia Healthcare Limited

Related Analysis

Need Detailed Export Data?

Data Source